83 FR 12956 - Office of the Director; Notice of Charter Renewal
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 83, Issue 58 (March 26, 2018)
National Institutes of Health
Federal Register Volume 83, Issue 58 (March 26, 2018)
| Page Range | 12956-12956 | |
| FR Document | 2018-05992 |
[Federal Register Volume 83, Number 58 (Monday, March 26, 2018)] [Notices] [Page 12956] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-05992] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director; Notice of Charter Renewal In accordance with Title 41 of the U.S. Code of Federal Regulations, Section 102-3.65(a), notice is hereby given that the Charter for the National Science Advisory Board for Biosecurity will be renewed for an additional two-year period on April 7, 2018. It is determined that the National Science Advisory Board for Biosecurity is in the public interest in connection with the performance of duties imposed on the National Institutes of Health by law, and that these duties can best be performed through the advice and counsel of this group. Inquiries may be directed to Claire Harris, Acting Director, Office of Federal Advisory Committee Policy, Office of the Director, National Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda, Maryland 20892 (Mail code 4875), [email protected] or Telephone (301) 496-2123. Dated: March 20, 2018. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018-05992 Filed 3-23-18; 8:45 am] BILLING CODE 4140-01-P
![12956 Federal Register / Vol. 83, No. 58 / Monday, March 26, 2018 / Notices
FDA’s website at https://www.fda.gov/ meetings and will make every effort to Musculoskeletal and Skin Diseases Research,
AdvisoryCommittees/default.htm and accommodate persons with disabilities. National Institutes of Health, HHS)
scroll down to the appropriate advisory If you require special accommodations Dated: March 20, 2018.
committee meeting link, or call the due to a disability, please contact Cindy Sylvia L. Neal,
advisory committee information line to Chee (see FOR FURTHER INFORMATION Program Analyst, Office of Federal Advisory
learn about possible modifications CONTACT) at least 7 days in advance of Committee Policy.
before coming to the meeting. the meeting. [FR Doc. 2018–05991 Filed 3–23–18; 8:45 am]
SUPPLEMENTARY INFORMATION: FDA is committed to the orderly BILLING CODE 4140–01–P
Agenda: The committee will discuss conduct of its advisory committee
new drug application (NDA) 210303 for meetings. Please visit our website at
plazomicin, sponsored by Achaogen, https://www.fda.gov/Advisory DEPARTMENT OF HEALTH AND
Inc., for the proposed indications for the Committees/AboutAdvisoryCommittees/ HUMAN SERVICES
treatment of complicated urinary tract ucm111462.htm for procedures on
infections and blood stream infections public conduct during advisory National Institutes of Health
in adults. committee meetings.
FDA intends to make background Notice of this meeting is given under Office of the Director; Notice of Charter
material available to the public no later the Federal Advisory Committee Act (5 Renewal
than 2 business days before the meeting. U.S.C. app. 2). In accordance with Title 41 of the
If FDA is unable to post the background Dated: March 20, 2018. U.S. Code of Federal Regulations,
material on its website prior to the Section 102–3.65(a), notice is hereby
Leslie Kux,
meeting, the background material will given that the Charter for the National
be made publicly available at the Associate Commissioner for Policy.
[FR Doc. 2018–06040 Filed 3–23–18; 8:45 am]
Science Advisory Board for Biosecurity
location of the advisory committee will be renewed for an additional two-
meeting, and the background material BILLING CODE 4164–01–P
year period on April 7, 2018.
will be posted on FDA’s website after It is determined that the National
the meeting. Background material is Science Advisory Board for Biosecurity
available at https://www.fda.gov/ DEPARTMENT OF HEALTH AND
HUMAN SERVICES is in the public interest in connection
AdvisoryCommittees/Calendar/ with the performance of duties imposed
default.htm. Scroll down to the on the National Institutes of Health by
National Institutes of Health
appropriate advisory committee meeting law, and that these duties can best be
link. National Institute of Arthritis and performed through the advice and
Procedure: Interested persons may Musculoskeletal and Skin Diseases; counsel of this group.
present data, information, or views, Notice to Close Meeting Inquiries may be directed to Claire
orally or in writing, on issues pending Harris, Acting Director, Office of Federal
before the committee. Written Pursuant to section 10(d) of the Advisory Committee Policy, Office of
submissions may be made to the contact Federal Advisory Committee Act, as the Director, National Institutes of
person on or before April 17, 2018. Oral amended, notice is hereby given of the Health, 6701 Democracy Boulevard,
presentations from the public will be following meeting. Suite 1000, Bethesda, Maryland 20892
scheduled between approximately 1:30 The meeting will be closed to the (Mail code 4875), harriscl@nih.gov or
p.m. and 2:30 p.m. Those individuals public in accordance with the Telephone (301) 496–2123.
interested in making formal oral provisions set forth in sections
presentations should notify the contact 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Dated: March 20, 2018.
person and submit a brief statement of as amended. The grant applications and David Clary,
the general nature of the evidence or the discussions could disclose Program Analyst, Office of Federal Advisory
arguments they wish to present, the confidential trade secrets or commercial Committee Policy.
names and addresses of proposed property such as patentable material, [FR Doc. 2018–05992 Filed 3–23–18; 8:45 am]
participants, and an indication of the and personal information concerning BILLING CODE 4140–01–P
approximate time requested to make individuals associated with the grant
their presentation on or before April 9, applications, the disclosure of which
2018. Time allotted for each would constitute a clearly unwarranted DEPARTMENT OF HEALTH AND
presentation may be limited. If the invasion of personal privacy. HUMAN SERVICES
number of registrants requesting to Name of Committee: National Institute of National Institutes of Health
speak is greater than can be reasonably Arthritis and Musculoskeletal and Skin
accommodated during the scheduled Diseases Special Emphasis Panel; NIAMS Center for Scientific Review; Notice of
open public hearing session, FDA may Loan Repayment Review. Closed Meetings
conduct a lottery to determine the Date: April 13, 2018.
speakers for the scheduled open public Time: 8:00 a.m. to 5:00 p.m. Pursuant to section 10(d) of the
hearing session. The contact person will Agenda: To review and evaluate contract Federal Advisory Committee Act, as
notify interested persons regarding their proposals. amended, notice is hereby given of the
Place: National Institute of Health/NIAMS, following meetings.
request to speak by April 10, 2018.
6701 Democracy Boulevard, Bethesda, MD The meetings will be closed to the
Persons attending FDA’s advisory 20892. public in accordance with the
sradovich on DSK3GMQ082PROD with NOTICES
committee meetings are advised that Contact Person: Kan Ma, Ph.D., Scientific
FDA is not responsible for providing Review Officer, National Institute Arthritis,
provisions set forth in sections
access to electrical outlets. Musculoskeletal, and Skin Diseases, NIH, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
For press inquiries, please contact the 6701 Democracy Blvd., Suite 814, Bethesda, as amended. The grant applications and
Office of Media Affairs at fdaoma@ MD 20892, (301) 451–4838, mak2@ the discussions could disclose
fda.hhs.gov or 301–796–4540. mail.nih.gov. confidential trade secrets or commercial
FDA welcomes the attendance of the (Catalogue of Federal Domestic Assistance property such as patentable material,
public at its advisory committee Program Nos. 93.846, Arthritis and and personal information concerning
VerDate Sep<11>2014 16:38 Mar 23, 2018 Jkt 244001 PO 00000 Frm 00019 Fmt 4703 Sfmt 4703 E:\FR\FM\26MRN1.SGM 26MRN1](https://thefederalregister.org/doc/83_FR_13014/page/1.svg)
Document Created: 2018-03-24 01:00:00
Document Modified: 2018-03-24 01:00:00
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| FR Citation | 83 FR 12956 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR